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Abstract
Background: Coping with the stresses of chronic disease is considered as a key factor in the perceived
impairment of health related quality of life (HRQL). Little is known though about these associations in chronic
kidney disease (CKD). The present study aimed to investigate the relationship of defensive coping and HRQL
among patients in different CKD stages, after adjusting for psychological distress, sociodemographic and disease-
related variables.
Methods: The sample consisted of 98 CKD patients, attending a university nephrology department. Seventy-nine
(79) pre-dialysis patients of disease stages 3 to 4 and 19 dialysis patients were included. HRQL was assessed by the
36-item Short-Form health survey (SF-36), defensive coping by the Rationality/Emotional Defensiveness (R/ED) scale
of the Lifestyle Defense Mechanism Inventory (LDMI) and psychological distress by the depression and anxiety
scales of the revised Hopkins Symptom CheckList (SCL-90-R). Regression analyses were carried out to examine the
association between SF-36 dimensions and defensive coping style.
Results: Patients on dialysis had worse scores on SF-36 scales measuring physical aspects of HRQL. In the fully
adjusted analysis, a higher defensive coping score was significantly associated with a lower score on the mental
component summary (MCS) scale of the SF-36 (worse mental health). In contrast, a higher defensive score showed
a small positive association with the physical component summary (PCS) scale of the SF-36 (better health), but this
was marginally significant.
Conclusions: The results provided evidence that emotional defensiveness as a coping style tends to differentially
affect the mental and the physical component of HRQL in CKD. Clinicians should be aware of the effects of long-
term denial and could examine the possibility of screening for defensive coping and depression in recently
diagnosed CKD patients with the aim to improve both physical and mental health.
Background
Chronic kidney disease (CKD) is a life-threatening con-
dition, persists for an extended period of time and
necessitates lifelong pharmacological treatment as well
as dietary restrictions. End-stage renal disease (ESRD)
imposes additional constraints due to the vital need for
regular sessions of renal dialysis. On these grounds,
CKD and especially ESRD have been defined as provok-
ing a state of prolonged distress [1].
Coping with the stresses of chronic disease plays a key
role in determining changes in health-related quality of
life (HRQL) [2]. It also reflects how well patients adjust
to chronic illnesses [3]. Several authors confirmed these
assumptions in spinal cord lesion [4], systemic lupus
erythematosus [5] and prostate cancer [6]. These find-
ings may have important clinical implications when con-
sidering the prognostic value of HRQL in several
chronic diseases, including ESRD: decreases in HRQL
have been repeatedly associated with increased
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[7,8] as well as limited adherence to ESRD regimens
[9,10] among hemodialysis (HD) patients.
Inherent in coping, emotion regulation embraces sev-
eral conscious and unconscious mechanisms, involved in
experiencing, perceiving, interpreting and dealing with
negative emotional states [11]. Maladjustment to
chronic illness has been traditionally associated with
avoidance and defensive inhibition of emotions [3].
Although reduced psychological distress might be
acknowledged and reported when avoidance or defen-
sive coping is employed [12,13], evidence suggested that
emotion-related physiological arousal persists [12].
Nevertheless, negative emotions remain unresolved,
bringing adverse effects on both physical [12-21] and
mental [14,15,22,23] health.
Early studies [24] showed evidence of defensive inhibi-
tion of emotions in HD patients, impeding psychological
adjustment [25]. The greater the occurrence of the
unconscious defense of denial, the more frequent the
adoption of emotion-focused coping strategies among
ESRD patients [1]. Systematic avoidance of disease stres-
ses via emotion-focused coping has been associated with
unfavourable mental health outcomes in peritoneal dia-
lysis (PD) patients [26] as well as with increased mortal-
ity in HD patients [27]. These effects were independent
of disease severity [26]. A recent study by Santos [28]
also showed that emotion-focused coping is associated
with worse physical and mental aspects of HRQL
among HD patients.
Closing the mind towards threatening information
may lead to silent intrapsychic tasks that adversely affect
both mental [15] and physical health [12]. It is then
important to evaluate the effectiveness of coping with
the stresses of chronic disease. According to Roesch and
Weiner [29], health related-quality of life seems a good
indicator of coping effectiveness. To our knowledge, lit-
tle evidence exists for coping with CKD (limited to con-
scious coping efforts of ESRD patients) and even less for
its impact on physical and mental well-being. The pre-
sent study sought to investigate the association of defen-
sive coping with both the mental and the physical
components of HRQL. Considering that not all aspects
of HRQL have been found related to CKD stage [30,31]
or severity [26], the present study assessed patients in
different CKD stages. Psychological distress was also
evaluated and controlled for together with socio-demo-
graphic and clinical variables.
Methods
Study design and participants
The present study was carrie do u ta tt h eu n i v e r s i t yo f
Ioannina nephrology department, which offers health
services to patients from north-western Greece. A cross-
sectional design was employed, in order to enable com-
parisons among CKD patients in different disease stages.
CKD stages were defined by the level of estimated glo-
merular filtration rate in a 24-hour urine collection
(eGFR-24h), as a measure of overall kidney function
[32,33].
Between March 15, 2007, and June 15, 2009, all
patients attending the university of Ioannina nephrology
department were consecutively included. Eligibility for
the study involved all patients, who (a) were aged 20
years and older, (b) had an adequate educational level as
well as an equivalent level of perception and compre-
hension, and (c) had read and signed the consent form.
Two hundreds thirty four (234) CKD patients met the
criteria. However, only 153 CKD patients agreed to par-
ticipate, while 55 of them failed to appear to the sched-
uled appointment to fill in the questionnaires. The
sample that was then formed included 98 CKD patients.
Seventy-nine (79) pre-dialysis patients of disease stages
3 to 4 and 19 dialysis patients were included. None of
the participants had a psychiatric diagnosis or treated
with psychoactive medication before or at the time of
the study.
An ethical approval for the study was obtained from
the scientific committee of the university of Ioannina
hospital, in accordance with the ethical standards of the
Helsinki Declaration.
Study measures
HRQL assessment
The 36-item Short Form health survey (SF-36) was
adopted for the assessment of HRQL. It is a generic
instrument, designed to measure eight health concepts,
including physical functioning, bodily pain, role limita-
tions due to physical health problems as well as due to
personal or emotional problems, emotional well-being,
social functioning, vitality and general health percep-
tions. Items from each concept are summed and
rescaled with a standard range of 0 to 100, where 100
represents the best HRQL. It also provides two general
indices, which refer to the physical component summary
(PCS) and the mental component summary (MCS)
scores. These are calculated using weights derived from
a national probability sample. SF-36 has been widely
used and validated by studies examining health-related
perceptions, quality of life and/or depression in different
medical conditions [34-36], including CKD [8,37]. SF-36
has been translated into several languages and found to
possess good psychometric features [38], including the
Greek version as well [39,40].
Defensive coping assessment
Defensive coping was assessed by the Rationality/Emo-
tional Defensiveness (R/ED) scale of the Lifestyle
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12 items, assessing individual differences in the fre-
quency that a person engages in rational, non-emotional
thought processes and behaviors (eg. “I try to under-
stand other people even if I do not like them"; “It r yt o
do what is sensible and logical"; etc.). Rating is based on
a 4-point frequency scale, ranging from (1) “almost
never” to (4) “almost always”. Items are summed to give
a range of 12 to 48, where 48 indicates excessive use of
unconscious defensiveness (i.e., repression and denial).
For its development, the Rationality/Anti-emotionality
questionnaire was used, which proved to be a reliable
predictor of cardiovascular disease and cancer [41,42].
B o t ht h eR / E Ds c a l ea l o n ea n dt h eL D Mi n v e n t o r yi n
total have been administered to several populations and
cultures and found to possess satisfactory psychometric
properties [43-46]. The Greek version of R/ED was
developed, according to the recommended forward and
backward translation procedure [47]. As this was the
first time that the R/ED was used in a Greek patient
population, reliability analysis was performed for this
sample. Internal consistency was found satisfactory with
a Cronbach’s alpha value being 0.76.
Psychological distress assessment
T h e1 3 - i t e md e p r e s s i o ns c a l ea n dt h e1 0 - i t e ma n x i e t y
scale of the revised Hopkins Symptom CheckList (SCL-
90-R) were used, in order to measure psychological
symptom status with a time reference of the past 7 days,
including the day of assessment. The depression scale
involves most typical symptoms of depressive syn-
dromes, including emotional, cognitive and somatic cor-
relates. The anxiety scale includes symptoms of
nervousness, tension, trembling, feelings of terror and
panic as well as some somatic correlates of anxiety.
Items are rated on a 5-point scale of symptom distress,
ranging from (0) “not all” to (4) “extremely”. Items from
each concept are summed and divided by the total num-
ber of responses on that concept with a range of 0 to 4,
where 4 indicates extreme psychological distress. The
SCL-90 inventory and its subscales have been widely
used as screening tools for the initial and follow-up
assessment of psychopathology in both psychiatric and
medical patients [48,49]. It has shown good internal
consistency and convergent validity in several clinical
studies internationally [50], including Greece [51].
Other clinical assessments and sociodemographics
Various sociodemographic and disease-related informa-
tion was collected, including gender and age, educa-
tional level, employment and marital status, personal
and family medical history, time of diagnosis, disease
etiology and stage as well as the method and duration of
dialysis treatment.
Statistical analysis
All analyses were performed using Stata (version 9.0).
Data was described as means and standard deviations
(SD) for continuous variables and as frequencies and
proportions for categorical variables. Pearson’s r was
applied to test for correlations among study variables.
T h eM a n n - W h i t n e yt e s tw a su s e df o rc o m p a r i s o n so f
ranked scores. Multiple linear regression was further
performed to assess the predictive power of defensive
coping for explaining differences in HRQL, while adjust-
ing for the effects of sociodemographic, clinical and psy-
chological variables.
Results
From the 234 patients eligible for inclusion, 136 refused
(81 immediately, while 55 patients although initially
agreed did not appear to the scheduled appointment).
Patients who refused did not differ in gender compared
to patients included in the study (43% vs 41% female
patients, p = 0.54), but they tended to be older (mean
age 57 vs 54, p = 0.04). They were also more likely to
be in pre-dialysis stages. For those who refused, 88%
were in the pre-dialysis stage (120/136) and 12% were in
ESRD (16/136), while for those who took part, the fig-
ures were 81% (79/98) and 19% (19/98) respectively (p =
0.03).
Table 1 presents the sociodemographic, clinical and
psychological characteristics of the included sample.
Most patients were married (86.7%) males (59%), being
at a pre-dialysis stage (80.6%). Their ages ranged from
20 to 80 years (53.7 ± 11.5). Less than half of the
patients were currently employed (42.9%). Their educa-
tion ranged from 6 to 16 years (10 ± 3.7). The diagnosis
of CKD had been established more than three years
before the conduction of the study for 78.5% of patients
and the underlying cause was identified as non-diabetic
nephropathy for 76.5% of patients. The mean score for
defensive coping was 37.07(±5.17), for depression 0.96
(±0.56) and for anxiety 0.48(±0.46).
Table 2 shows the mean scores and SDs on the SF-36
dimensions by the time since the diagnosis of CKD and
by disease stage. Patients who were diagnosed with CKD
more than 3 years ago and dialysis patients had signifi-
cantly lower scores on PCS (p < 0.001), including physi-
cal functioning (p <0 . 0 5a n dp <0 . 0 0 1r e s p e c t i v e l y ) ,
bodily pain (p <0 . 0 0 1a n dp < 0.05 respectively) and
general health (p < 0.001 and p < 0.01 respectively).
Nonsignificant differences were obtained for MCS. Only
patients who were diagnosed more than 3 years ago
reported a significant greater impairment of social func-
tioning (p < 0.01).
The correlation coefficients for SF-36 dimensions,
defensive coping, depression and anxiety are presented
on Table 3. Significant negative associations were
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well as for MCS, defensive coping, depression and anxi-
ety (p < 0.01). It is noted that defensive coping was not
associated with PCS but it was significantly associated
with depression (p < 0.05).
Association between SF-36 dimensions and defensive
coping scores
Results of the regression analysis are shown in Table 4.
In the fully adjusted model, a higher defensive coping
score was significantly associated with a lower MCS
score (worse mental health) but a higher PCS score
(better physical health), although the latter was margin-
ally significant (b = 0.26, p = 0.046). Since in the uni-
variate analysis (Table 3) there was no association
between defensive coping and PCS scores, we repeated
the analysis by excluding depression to assess the possi-
bility that the latter had a negative confounding effect
on the association between PCS and defensive coping.
Indeed, the analysis showed that this was true, since the
beta coefficient for defensiveness was reduced in this
analysis (b = 0.19, p = 0.23). R
2- values for the fully
adjusted PCS and MCS models were 0.70 and 0.73
respectively.
Discussion
HRQL has been considered as a good indicator of physi-
cal and psychological well-being in chronic disease [29]
as well as a strong predictor of adherence [9,10], mor-
bidity [7] and mortality [7,8] in ESRD. It has been
argued that perceived impairment of HRQL is mediated
by patients’ efforts to cope with the stresses of the dis-
ease [26]. Maintaining a satisfactory level of quality of
life is then associated with effective coping [29].
Defensive coping, as introduced by S. Freud [52],
represents a distortion of unwelcome reality [53]: it
alters the way a stressful situation is perceived, by expel-
ling disturbing thoughts or emotions from conscious
awareness. Its functions resemble the ones of medical
defense mechanisms but in regard to mental health [13].
Physical disease is considered to evoke defense-related
emotions, such as fear, anxiety, sadness and anger [13].
Thus, the role of psychological defense is to guard indi-
viduals against disease-related information that induces
distress and threatens psychological equilibrium. In the
context of physical health conditions, evidence suggested
that extended use of emotional defensiveness (e.g.
denial) might be palliative but often at the cost of men-
tal health [14,15,22,23] and, in the long run, of physical
health [12-21] as well.
The present study aimed to investigate the association
of emotional defensiveness as a coping style with the
mental and physical components of HRQL among CKD
patients in different stages. After controlling for psycho-
logical distress, sociodemographic and disease-related
variables, our findings revealed that emotional defensive-
ness was indeed an explanatory variable for HRQL.
However it had a distinct, contrasting impact on mental
and physical outcomes.
Table 1 Sociodemographic, clinical and psychological
characteristics in chronic kidney disease patients
(N = 98)
SOCIODEMOGRAPHIC, CLINICAL AND
PSYCHOLOGICAL VARIABLES
N (%) or mean
(SD)
GENDER Male 58(59.18%)
Female 40(40.82%)
AGE 20-39 yrs 6(6.12%)
40-59yrs 53(54.08%)
>60 yrs 39(39.80%)
EDUCATION 6 yrs 37(37.76%)
9 yrs 15(15.30%)
12 yrs 26(26.54%)
>12 yrs 20(20.40%)
MARITAL STATUS Married 85(86.74%)
Single 6(6.12%)
Divorced 6(6.12%)
Widower 1(1.02%)
EMPLOYMENT STATUS Employed 42(42.86%)
Unemployed 2(2.04%)
Retired 31(31.63%)
Domestic 21(21.43%)
Student 2(2.04%)
CLINICAL VARIABLES Disease stage
Pre-dialysis 79(80.61%)
Dialysis 19(19.39%)
Time since diagnosis
<1 yr 1(1.02%)
1-3 yrs 20(20.41%)
>3 yrs 77(78.57%)
CKD etiology
Diabetic nephropathy 23(23.47%)
Non-diabetic
nephropathy
75(76.53%)
PSYCHOLOGICAL
VARIABLES
Defensive coping
score
a
37.07(5.17)
Depression score
b 0.96(0.56)
Anxiety score
c 0.48(0.46)
a Scores on the Rationality/Emotional Defensiveness (R/ED) scale (range: 12-
48) of the Lifestyle Defense Mechanism Inventory (LDMI).
b,c Scores on the depression (range: 0-4) and the anxiety (range: 0-4) scales of
the 90-item revised Hopkins Symptom CheckList (SCL-90-R).
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provided evidence that greater use of emotional defen-
siveness is associated with more depressive symptoms
and a deteriorated mental component of HRQL. These
adverse effects of defensive coping were apparent,
regardless of disease stage and the time that occurred
since CKD was diagnosed. Previous studies also showed
that both conscious and unconscious avoidance of dis-
ease stresses is associated with increased depressive
symptoms and a poor total mental health functioning in
various physical disorders [22,23], including ESRD
[25,26,28]. A high prevalence of depressive symptoms
has been also systematically recorded in CKD patients
[54]. These homogeneous findings are theoretically
meaningful in that, defending against painful emotions
impedes the process of grief and gives rise to essential
depression. While grief involves working on disease-
related loss (e.g. loss of independency, self-image, etc.)
and reaching an adaptive resolution [55], depression
reflects the tendency to defensively avoid (e.g. denial)
loss-related emotions or information; it represents an
absence of desire and intrapsychic life [56], leading to a
rather maladaptive resolution [55].
However, these adverse effects of defensive coping
were restricted to mental well-being only. It was inter-
esting to find that emotional defensiveness tended to
predict a slightly better physical aspect of HRQL. In the
unadjusted association though (see table 3), emotional
defensiveness was not associated with PCS, a finding
which is explained by the negative confounding effect of
depression on this association. It should be noted, how-
ever, that the adjusted association of emotional defen-
siveness and PCS was marginally significant. Therefore,
the most robust finding of the present study was the
absence of a negative effect of defensive coping on phy-
sical well-being.
Opposed to this, most findings so far suggested that
patients with several health conditions, using long-term
avoidant or defensive coping, tended to report a deterio-
rated physical well-being [19,57]. When the present
research team examined the same psychological vari-
ables as here in patients with essential hypertension, a
trend for a negative association was observed for emo-
tional defensiveness and PCS. It could be assumed then
that the present finding might be disease specific: for
CKD patients, defensive coping may influence mental
and physical well-being in conflicting ways. Taylor and
her colleagues [58] arrived at similar conclusions when
examined patients awaiting lung transplantation: active
coping was associated with better physical health in
chronic obstructive pulmonary disease but not in cystic
fibrosis.
CKD is a health condition that persists over an
extended period of time and brings no obvious
Table 2 Mean SF-36 scores by time since diagnosis and disease stage in chronic kidney disease patients (N = 98)
TIME SINCE DIAGNOSIS
Mean(SD)
DISEASE STAGE
Mean(SD)
≤3 years
(N = 21)
>3 years
(N = 77)
Pre-dialysis
(N = 79)
Dialysis
(N = 19)
Total
(N = 98)
PCS
b 51.97(7.06) 45.24(8.18)
*** 48.32(7.40) 39.87(8.99)
*** 46.68(8.39)
MCS
c 45.20(10.15) 47.75(10.54) 47.52(10.25) 45.90(11.48) 47.20(10.46)
Physical functioning 82.61(18.61) 74.67(18.99)
* 80.44(15.19) 59.47(24.31)
*** 76.37(19.10)
Role/Physical 59.52(42.18) 74.35(36.49) 73.42(35.65) 61.84(46.67) 71.17(38.05)
Bodily pain 94.33(13.53) 71(28.22)
*** 79.59(23.63) 61.05(36.76)
* 76.00(27.46)
General health 67.95(19.73) 50.53(17.92)
*** 57.48(18.92) 40.89(16.77)
** 54.26(19.58)
Vitality 63.33(23.62) 59.87(20.35) 61.77(20.20) 55.78(24.10) 60.61(21.02)
Social functioning 86.90(16.52) 72.07(24.90)
** 77.84(22.37) 64.47(28.34) 75.25(24.07)
Role/Emotional 58.73(37.86) 74.02(36.52) 74.68(34.26) 54.38(44.73) 70.74(37.15)
Mental Health 64.76(18.57) 69.76(20.31) 68.75(19.73) 68.42(21.49) 68.69(19.97)
a Lower scores indicate worse health;
bPCS: Physical Component Summary score;
cMCS: Mental Component Summary score
*p <.05, **p <.01 and ***p <.001, Mann-Whitney U test for comparisons of ranked scores.
Table 3 Pearson’s correlation coefficients among SF-36
physical component summary (PCS) and mental
component summary (MCS), defensive coping score,
depression score and anxiety score in chronic kidney
disease patients (N = 98)
12 3 4 5
1. Physical component
summary
1
2. Mental component
summary
0.284** 1
3. Defensive coping score
a 0.039 -0.384** 1
4. Depression score
b -0.532** -0.738** 0.236* 1
5. Anxiety score
c -0.394** -0.554** 0.065 0.638** 1
a Scores on the Rationality/Emotional Defensiveness (R/ED) scale (range: 12-
48) of the Lifestyle Defense Mechanism Inventory (LDMI).
b,c Scores on the depression (range: 0-4) and the anxiety (range: 0-4) scales of
the 90-item revised Hopkins Symptom CheckList (SCL-90-R).
*p < 0.05, **p < 0.01
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assume then that closing the mind towards the potential
threats of the disease is further facilitated by this silent
progress of CKD. Such an assumption may gain
grounds, when considering that the study sample con-
sisted mainly of pre-dialysis patients, who reported a
significantly higher physical aspect of HRQL compared
to dialysis patients. Therefore, perceived physical health
appears optimal, since limitations due to health condi-
tion are easy to ignore in pre-dialysis stages, although at
the cost of mental well-being. For ESRD though, pre-
vious research did establish a relationship between emo-
tion-focused coping and a deteriorated physical aspect
of HRQL [28]. The adoption of emotion-focused strate-
gies has been also positively associated with defensive
coping (i.e. denial) among ESRD patients [1]. On these
grounds, it might be appropriate to consider our finding
in relation with CKD stage: the effects of emotional
defensiveness on perceived physical health may not
apply to ESRD, due to the small number of the dialysis
patients enrolled. Future research is certainly needed to
clarify this association with regard to CKD stage.
While no negative effects of emotional defensiveness
were observed on perceived physical health at least for
pre-dialysis patients, it has not been possible to con-
clude whether this finding also applies to actual physical
health, due to the lack of relevant data for the study
sample. Previous findings suggested that, in the long
run, defensive coping may adversely affect actual physi-
cal health through certain patterns of behaviour. Deva-
luation of physical symptoms, failure to seek and
comply with medical recommendations and rehabilita-
tion as well as an increased risk of comorbidity and
mortality have all been associated with defensive coping
in several chronic disease [18-21]. Limited adherence to
ESRD management has been repeatedly observed in dia-
l y s i sp a t i e n t sa sw e l l[ 5 9 ] .T h e s ep a t t e r n so fb e h a v i o u r
might be indeed indicative of the maladaptive functions
of defensive denial [14]. Disease-related information (i.e.
physical symptoms and medical recommendations)
might have been subject to defensive functioning and
thus overlooked. On these grounds, it seems worthwhile
for future research to examine associations of emotional
defensiveness and actual physical health in both cross-
sectional and prospective studies.
In summary, the results of the present study indi-
cated that emotional defensiveness is differentially
associated with mental and physical components of
HRQL in CKD: perceived mental health tended to
deteriorate, while perceived physical health tended to
slightly improve. These findings may have important
implications for the management of CKD patients as
well as the orientation of psychosocial interventions. It
might be important for clinicians to consider that pre-
Table 4 Association of SF-36 physical component summary (PCS) and mental component summary (MCS) scores with
sociodemographic, clinical and psychological variables
DEPENDENT VARIABLES INDEPENDENT VARIABLES B (95% CI)
a
PCS
b Depression score
c -7.96 (-10.65, -5.26)***
Anxiety score
d -0.54 (-2.73, 3.82)
Defensive coping score
e 0.26 (0.004, 0.51)*
Age -.07 (-0.25, 0.10)
Female
f - 6.38 (-9. 64, -3.13)***
Dialysis
g - 8.48 (-11.28, -5.68)***
>3 years since diagnosis
h -1.94 (-5.49, 1.59)
MCS
b Depression score
c -9.15 (-12.31, -5.99)***
Anxiety score
d -6.35 (-10.19, -2.51)**
Defensive coping score
e -0.51 (-0.81, -0.21)**
Age 0.13 (-0.06, 0.34)
Female
f 8.55 (4.74, 12.36)***
Dialysis
g -3.37 (-6.65, -0.09)*
>3 years since diagnosis
h 6.25 (2.09, 10.40) **
a Beta coefficients (95% Confidence Intervals) from linear regression models adjusted for education, marital status, employment status and all variables listed on
table.
b Lower scores indicate worse health
c,d Scores on the depression (range: 0-4) and the anxiety (range: 0-4) scales of the 90-item revised Hopkins Symptom CheckList (SCL-90-R). e Scores on the
Rationality/Emotional Defensiveness (R/ED) scale (range: 12-48) of the Lifestyle Defense Mechanism Inventory (LDMI)
e Scores on the Rationality/Emotional Defensiveness (R/ED) scale (range: 12-48) of the Lifestyle Defense Mechanism Inventory (LDMI).
f Vs male
g Vs pre-dialysis patients
h Vs ≤3 years since diagnosis
* p < 0.05,
** p < 0.01,
*** p < 0.001
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necessarily have good mental health as well. In addi-
tion, physical health may also deteriorate as effects of
long-term emotional defensiveness become apparent.
Succeeding a moderate defensive coping with CKD
may indeed facilitate psychological adjustment and
possibly promote physical health as well. Future
research is certainly needed to confirm and further
examine this disease-specific impact of defensive cop-
ing on health related quality of life.
Limitations
The findings of the present study should be considered
in the context of certain limitations. First, this was a
cross-sectional study and, therefore, issues of temporal
association cannot be examined. Although it is antici-
pated that coping style is a relatively stable personality
characteristic, we do not have data on the stability of
the defensive coping style and we cannot exclude the
possibility that the severity of the disease may influence
the coping style or modify its characteristics. Second, no
objective data regarding CKD severity and/or comorbid
conditions was collected for the study sample and, thus,
it is not possible to examine associations of emotional
defensiveness and actual physical health condition.
Third, the sample may have not efficiently represented
CKD and especially ESRD patients in Greece, as a
result of including a small number of patients from a
single academic centre. Hence, the generalisability of
the results might be somewhat limited. In addition, it
is not possible to conclude whether the effects of emo-
tional defensiveness on perceived physical health also
a p p l yt oE S R Da n dt og e n e r a l i z eo u rf i n d i n g st ot h e
broader population of dialysis patients in Greece.
Another factor that may have limited the external
validity of the results is the proportion of CKD
patients accepting to take part. We found no differ-
ences in gender between those who refused and those
who accepted to take part. However, it was more likely
for patients who refused to be slightly older as well as
in pre-dialysis stages. There is no indication though
that the reason for their refusal was related to the
study aims, in order to introduce selection bias to the
study. Participation to the study was voluntary and
most of the patients that refused reported lack of time
o ri n t e r e s t .T oo u ro p i n i o n ,p a t i e n t sw h or e f u s e d
appeared less motivated to take part due to the fact
that additional research was carried out at that time
and they were asked to participate to all.
Conclusions
The present study investigated the association between
emotional defensiveness as a coping style and perceived
impairment of physical and mental well-being in CKD.
Psychological distress, sociodemographic and clinical
variables were adjusted to isolate the impact of emo-
tional defensiveness. The results confirmed previous
findings, suggesting that defensive coping does relate to
worse mental components of HRQL. However, no nega-
tive effects of emotional defensiveness were observed for
the physical aspects of HRQL. Instead, a marginally sig-
nificant positive effect was obtained. Although these
findings were liable to certain limitations, they have still
posed several issues to consider in both clinical practice
and future research: good physical health may not be
necessarily accompanied by good mental health and
physical health may worsen as a result of long-term
emotional defensiveness. Assessment of defensive coping
and depression in recently diagnosed CKD patients may
be warranted to improve both physical and mental
health of CKD patients.
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